News

Published on 10 Oct 2022 on Investing.com

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In...


Article preview image

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In...

NYSE.HKD price evolution
NYSE.QNGY price evolution
NASDAQ.XELA price evolution
CRYPTO.TRX price evolution
NASDAQ.SYTA price evolution
NASDAQ.DKNG price evolution
NYSE.TAL price evolution
NASDAQ.APDN price evolution
NASDAQ.NVAX price evolution
NASDAQ.WYNN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Rockville biotech Shuttle Pharma inks deal to advance key drug - Washington Business Journal

Welcome to Bio Briefing, a weekly rundown of the biggest moves in Greater Washington's biotech...

The Business Journals 10 Mar 2023

Newsflash: Novavax, Inc. (NASDAQ:NVAX) Analysts Have Been Trimming Their Revenue Forecasts

Today is shaping up negative for Novavax, Inc. (NASDAQ:NVAX) shareholders, with the analysts deli...

Simply Wall St. via Yahoo Finance 5 Mar 2023

Jim Cramer Claims He Knew One Stock Was 'Worthless' Before Wednesday's Collapse

Shares of Novavax Inc. took a hit this week after the company said there is substantial doubt abo...

TheStreet.com 3 Mar 2023

Covid Vaccine Maker Novavax’s Flameout Mints Shorts $2.7 Billion

(Bloomberg) -- Waning interest in Covid-19 vaccines has left a long-standing drug developer, Nova...

Bloomberg via Yahoo Finance 2 Mar 2023

Novavax Stock: The Gig Is Up (NASDAQ:NVAX)

The stock soared to amazing heights on exuberance around the approved covid vaccine, but now the ...

Seeking Alpha 1 Mar 2023

Novavax Ushers New CEO On Uncertainty Concerns, Says It Needs To Work On Competitive COVID-19...

COVID-19 vaccine maker Novavax Inc (NASDAQ: NVAX) shares plunged after it raised doubts about its...

Benzinga via Yahoo Finance 1 Mar 2023

Stock movers: Reata and Sarepta soar, while Novavax and Marqeta sink

Here are the stocks in focus early in Wednesday’s trading session. Reata Pharmaceuticals Inc.’s R...

MarketWatch 1 Mar 2023

Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down

Novavax, Inc. NVAX incurred a loss of $2.28 per share for fourth-quarter 2022, which was signific...

Zacks via Yahoo Finance 1 Mar 2023

Novavax shares slump as vaccine maker warns of its ability to stay in business By Investing.com

Novavax shares slump as vaccine maker warns of its ability to stay in business

Investing.com 1 Mar 2023

Novavax sinks on concerns about COVID vaccine maker's prospects

Novavax Inc's shares plunged to a three-year low on Wednesday, a day after the COVID-19 vaccine...

Reuters via Yahoo News 1 Mar 2023